| Robert H Bevis, MD | |
|
1600 Lakeland Hills Blvd, Lakeland, FL 33805 | |
| (863) 680-7190 | |
| (866) 264-8519 |
| Full Name | Robert H Bevis |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 45 Years |
| Location | 1600 Lakeland Hills Blvd, Lakeland, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003887621 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | ME41810 (Florida) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Lakeland Regional Medical Center | Lakeland, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Watson Clinic Llp | 1456258979 | 373 |
News Archive
There's much talk on Capitol Hill about the tax cuts included in the Republican health plans, but unless you are a frequent user of tanning beds or have personal wealth that puts you in the top 1 percent, you might not feel much effect from them.
InterMune, Inc. today reported that new data was presented at the European Respiratory Society (ERS) Annual Congress supporting the longer-term safety and tolerability of Esbriet(pirfenidone) in patients with idiopathic pulmonary fibrosis (IPF), a devastating lung disease.
Kolltan Pharmaceuticals, Inc. announced today that it has raised an additional $5 million to close its Series A preferred stock financing at $40 million. Participants in the Series A financing, originally announced in January 2009, include Purdue Pharma, L.P., HBM BioCapital L.P., the Pritzker/Vlock family, and other substantial private life science investors.
A working party report released today calls for the co-ordinated management of chronic disease across primary and secondary care in the UK.
› Verified 1 days ago
| Entity Name | Watson Clinic Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316940695 PECOS PAC ID: 1456258979 Enrollment ID: O20031215000113 |
News Archive
There's much talk on Capitol Hill about the tax cuts included in the Republican health plans, but unless you are a frequent user of tanning beds or have personal wealth that puts you in the top 1 percent, you might not feel much effect from them.
InterMune, Inc. today reported that new data was presented at the European Respiratory Society (ERS) Annual Congress supporting the longer-term safety and tolerability of Esbriet(pirfenidone) in patients with idiopathic pulmonary fibrosis (IPF), a devastating lung disease.
Kolltan Pharmaceuticals, Inc. announced today that it has raised an additional $5 million to close its Series A preferred stock financing at $40 million. Participants in the Series A financing, originally announced in January 2009, include Purdue Pharma, L.P., HBM BioCapital L.P., the Pritzker/Vlock family, and other substantial private life science investors.
A working party report released today calls for the co-ordinated management of chronic disease across primary and secondary care in the UK.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Robert H Bevis, MD 1600 Lakeland Hills Blvd, Lakeland, FL 33805-3065 Ph: (863) 680-7000 | Robert H Bevis, MD 1600 Lakeland Hills Blvd, Lakeland, FL 33805 Ph: (863) 680-7190 |
News Archive
There's much talk on Capitol Hill about the tax cuts included in the Republican health plans, but unless you are a frequent user of tanning beds or have personal wealth that puts you in the top 1 percent, you might not feel much effect from them.
InterMune, Inc. today reported that new data was presented at the European Respiratory Society (ERS) Annual Congress supporting the longer-term safety and tolerability of Esbriet(pirfenidone) in patients with idiopathic pulmonary fibrosis (IPF), a devastating lung disease.
Kolltan Pharmaceuticals, Inc. announced today that it has raised an additional $5 million to close its Series A preferred stock financing at $40 million. Participants in the Series A financing, originally announced in January 2009, include Purdue Pharma, L.P., HBM BioCapital L.P., the Pritzker/Vlock family, and other substantial private life science investors.
A working party report released today calls for the co-ordinated management of chronic disease across primary and secondary care in the UK.
› Verified 1 days ago
Dr. Elijah Kim, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1324 Lakeland Hills Blvd, Lakeland, FL 33805 Phone: 863-687-1321 Fax: 863-284-1786 | |
Dr. Julia Mcneice, DO Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1600 Lakeland Hills Blvd, Lakeland, FL 33805 Phone: 863-680-7190 Fax: 866-264-8519 | |
Christian Abreu-ramirez, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1324 Lakeland Hills Blvd, Lakeland, FL 33805 Phone: 863-687-1100 | |
Dr. Lilliam S. Chiques-colon, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1600 Lakeland Hills Blvd, Lakeland, FL 33805 Phone: 863-680-7000 Fax: 866-264-8519 | |
Dr. Lijian Wang, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1600 Lakeland Hills Blvd, Lakeland, FL 33805 Phone: 863-680-7000 Fax: 866-264-8519 | |
Eric Lipson, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1600 Lakeland Hills Blvd, Lakeland, FL 33805 Phone: 863-680-7190 Fax: 866-264-8519 |